International · World

Europe gives green light to the first weight loss pill

1 sourceFirst reported 1 day agoUpdated 1 day ago

AI summary: catch up in 20 seconds

The European Commission has approved the first weight loss pill, semaglutide, in a 25 mg dosage.
This new oral formulation eliminates the need for weekly injections for weight management.
Clinical trials have shown that users can experience an average weight loss of up to 17%.
The approval marks a significant development in obesity treatment options available in Europe.

Generated by AI from the 1 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 1 sources below · always verify with the originals

All coverage (1)

In this storyEU Affairs

Sign in to join the discussion.

No comments yet. Be the first to join the discussion.

AI summary: catch up in 20 seconds

The European Commission has approved the first weight loss pill, semaglutide, in a 25 mg dosage.
This new oral formulation eliminates the need for weekly injections for weight management.
Clinical trials have shown that users can experience an average weight loss of up to 17%.
The approval marks a significant development in obesity treatment options available in Europe.

Generated by AI from the 1 sources below · always verify with the originals